Genesis of a $5b collapse: Inside Dan Collins’ rise and fall
The recriminations have begun following the collapse of the cancer care giant, once valued at $5 billion. At the centre is the Brisbane boy who made it big.
GenesisCare founder Dan Collins doesn’t want to talk about his personal loan from China Resources, a major shareholder of the failed oncology group. But everyone else does.
The state-backed company has briefed lawyers at Ropes & Gray in Hong Kong to try to recoup some of its money from the loan, secured against Collins’ now-worthless equity in the cancer care services group.
Carrie LaFrenzSenior reporterCarrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
Jemima WhyteSenior reporterJemima Whyte writes on business, specialising in companies, capital markets and innovation. Jemima has reported on business for The Australian Financial Review for more than 13 years. Email Jemima at jemima.whyte@afr.com
